Author
Listed:
- Kali R. Iyer
(University of Toronto)
- Kaddy Camara
(Boston University
Clark+Elbing LLP)
- Martin Daniel-Ivad
(University of Toronto)
- Richard Trilles
(Boston University)
- Sheila M. Pimentel-Elardo
(University of Toronto)
- Jen L. Fossen
(University of Wisconsin School of Medicine and Public Health
University of Wisconsin)
- Karen Marchillo
(University of Wisconsin School of Medicine and Public Health
University of Wisconsin)
- Zhongle Liu
(University of Toronto)
- Shakti Singh
(Division of Infectious Disease, The Lundquist Institute for Biomedical Innovation Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center)
- José F. Muñoz
(Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard)
- Sang Hu Kim
(University of Toronto)
- John A. Porco
(Boston University)
- Christina A. Cuomo
(Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard)
- Noelle S. Williams
(University of Texas Southwestern Medical School)
- Ashraf S. Ibrahim
(Division of Infectious Disease, The Lundquist Institute for Biomedical Innovation Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center
David Geffen School of Medicine, UCLA)
- John E. Edwards
(Division of Infectious Disease, The Lundquist Institute for Biomedical Innovation Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles (UCLA) Medical Center
David Geffen School of Medicine, UCLA)
- David R. Andes
(University of Wisconsin School of Medicine and Public Health
University of Wisconsin)
- Justin R. Nodwell
(University of Toronto)
- Lauren E. Brown
(Boston University)
- Luke Whitesell
(University of Toronto)
- Nicole Robbins
(University of Toronto)
- Leah E. Cowen
(University of Toronto)
Abstract
Candida auris is an emerging fungal pathogen that exhibits resistance to multiple drugs, including the most commonly prescribed antifungal, fluconazole. Here, we use a combinatorial screening approach to identify a bis-benzodioxolylindolinone (azoffluxin) that synergizes with fluconazole against C. auris. Azoffluxin enhances fluconazole activity through the inhibition of efflux pump Cdr1, thus increasing intracellular fluconazole levels. This activity is conserved across most C. auris clades, with the exception of clade III. Azoffluxin also inhibits efflux in highly azole-resistant strains of Candida albicans, another human fungal pathogen, increasing their susceptibility to fluconazole. Furthermore, azoffluxin enhances fluconazole activity in mice infected with C. auris, reducing fungal burden. Our findings suggest that pharmacologically targeting Cdr1 in combination with azoles may be an effective strategy to control infection caused by azole-resistant isolates of C. auris.
Suggested Citation
Kali R. Iyer & Kaddy Camara & Martin Daniel-Ivad & Richard Trilles & Sheila M. Pimentel-Elardo & Jen L. Fossen & Karen Marchillo & Zhongle Liu & Shakti Singh & José F. Muñoz & Sang Hu Kim & John A. Po, 2020.
"An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris,"
Nature Communications, Nature, vol. 11(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-20183-3
DOI: 10.1038/s41467-020-20183-3
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-20183-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.